Cargando…
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremia
BACKGROUND: Consideration to add empiric MRSA therapy with vancomycin is a common clinical dilemma. However, vancomycin overuse has important adverse events. MRSA colonization screening is commonly performed for infection control. We hypothesized that in cases of S. aureus bacteremia, a score based...
Autores principales: | Butler-Laporte, Guillaume, Cheng, Matthew P., McDonald, Emily G., Lee, Todd C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996459/ https://www.ncbi.nlm.nih.gov/pubmed/29890954 http://dx.doi.org/10.1186/s12879-018-3182-x |
Ejemplares similares
-
Nasal Screening for MRSA: Different Swabs – Different Results!
por: Warnke, Philipp, et al.
Publicado: (2014) -
Predicting Risk for Death from MRSA Bacteremia
por: Pastagia, Mina, et al.
Publicado: (2012) -
Simplified risk stratification criteria for identification of patients with MRSA bacteremia at low risk of infective endocarditis: implications for avoiding routine transesophageal echocardiography in MRSA bacteremia
por: Buitron de la Vega, P., et al.
Publicado: (2015) -
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?
por: Federman, Daniel G., et al.
Publicado: (2020) -
117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)